🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase IIb, randomized, double-blind, placebo-controlled study to ...
Status
Completed
Location
Sunpharma site no. 20
Start Date
2020-12-22
Trial ID
NCT04506463
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays and other types of rad...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2012-11
Trial ID
NCT01672892
Treatments Being Tested
The purpose of study is to compare the effectiveness of the Day-5 fixed adm...
Status
Unknown
Location
Multiple Locations
Start Date
2016-01
Trial ID
NCT02635607
Treatments Being Tested
The aim of the study is to assess the safety, and immunogenicity of AZD2816...
Status
Completed
Location
Research Site
Start Date
2021-06-27
Trial ID
NCT04973449
The purpose of this study is to evaluate validation and clinical assessment...
Status
Unknown
Location
Lithuanian University of Health Sciences
Start Date
2014-02
Trial ID
NCT02054676
Intravitreal triamcinolone acetonide is a well-known method of treatment of...
Status
Unknown
Location
Ain Shams University
Start Date
2019-03-13
Trial ID
NCT04069780
Single-center, single-dose, placebo-controlled, open-label trials were used...
Status
Completed
Location
Wuhan Infectious Disease Hospital
Start Date
2020-05-27
Trial ID
NCT04239313
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide and dexamet...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2005-05
Trial ID
NCT00258245
Treatments Being Tested
There are four populations in Recombinant Mycobacterium tuberculosis Vaccin...
Status
Completed
Location
Shanghai Public Health clinical Center
Start Date
2018-04-16
Trial ID
NCT03026972
Treatments Being Tested
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2006-06
Trial ID
NCT00523848
Treatments Being Tested